139 related articles for article (PubMed ID: 35775110)
1. Phospholipase D1 promotes cervical cancer progression by activating the RAS pathway.
Song M; Meng Q; Jiang X; Liu J; Xiao M; Zhang Z; Wang J; Bai H
J Cell Mol Med; 2022 Aug; 26(15):4244-4253. PubMed ID: 35775110
[TBL] [Abstract][Full Text] [Related]
2. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
[No Abstract] [Full Text] [Related]
3. Promotion of cell autophagy and apoptosis in cervical cancer by inhibition of long noncoding RNA LINC00511 via transcription factor RXRA-regulated PLD1.
Shi Y; Liu M; Huang Y; Zhang J; Yin L
J Cell Physiol; 2020 Oct; 235(10):6592-6604. PubMed ID: 32067228
[TBL] [Abstract][Full Text] [Related]
4. Combination of Sodium Cantharidinate with Cisplatin Synergistically Hampers Growth of Cervical Cancer.
Chen X; Zhou M; Fan W; Yang M; Yang L
Drug Des Devel Ther; 2021; 15():171-183. PubMed ID: 33469269
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells.
Kang DW; Park MH; Lee YJ; Kim HS; Kwon TK; Park WS; Min do S
J Biol Chem; 2008 Feb; 283(7):4094-104. PubMed ID: 18084005
[TBL] [Abstract][Full Text] [Related]
6. DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway.
Bai H; Song M; Jiao R; Li W; Zhao J; Xiao M; Jin M; Zhang Z; Deng H
J Cell Mol Med; 2021 Oct; 25(19):9306-9318. PubMed ID: 34435746
[TBL] [Abstract][Full Text] [Related]
7. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
Jiang D; Ren C; Yang L; Li F; Yang X; Zheng Y; Ji X; Tian Y
J Obstet Gynaecol Res; 2021 Jul; 47(7):2433-2441. PubMed ID: 34028125
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic inhibition of phospholipase D1 suppresses hepatocellular carcinoma.
Xiao J; Sun Q; Bei Y; Zhang L; Dimitrova-Shumkovska J; Lv D; Yang Y; Cao Y; Zhao Y; Song M; Song Y; Wang F; Yang C
Clin Sci (Lond); 2016 Jul; 130(13):1125-36. PubMed ID: 27129182
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase D1 mediates bFGF-induced Bcl-2 expression leading to neurite outgrowth in H19-7 cells.
Yoon SN; Kim KS; Cho JH; Ma W; Choi HJ; Kwon SJ; Han JS
Biochem J; 2012 Jan; 441(1):407-16. PubMed ID: 21916846
[TBL] [Abstract][Full Text] [Related]
10. The progesterone receptor as a transcription factor regulates phospholipase D1 expression through independent activation of protein kinase A and Ras during 8-Br-cAMP-induced decidualization in human endometrial stromal cells.
Cho JH; Yoon MS; Koo JB; Kim YS; Lee KS; Lee JH; Han JS
Biochem J; 2011 May; 436(1):181-91. PubMed ID: 21284604
[TBL] [Abstract][Full Text] [Related]
11. Role of phospholipase D in parathyroid hormone type 1 receptor signaling and trafficking.
Garrido JL; Wheeler D; Vega LL; Friedman PA; Romero G
Mol Endocrinol; 2009 Dec; 23(12):2048-59. PubMed ID: 19837945
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
[TBL] [Abstract][Full Text] [Related]
14. PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas.
Gozgit JM; Pentecost BT; Marconi SA; Ricketts-Loriaux RS; Otis CN; Arcaro KF
Br J Cancer; 2007 Sep; 97(6):809-17. PubMed ID: 17726467
[TBL] [Abstract][Full Text] [Related]
15. RhoC mediates invasion and migration of CaSki cells through the Rho-associated serine-threonine protein kinase 1 signaling pathway.
Chen R; Cheng Y; Zhang Y; Li Z; Geng L
Int J Gynecol Cancer; 2014 Feb; 24(2):184-91. PubMed ID: 24457551
[TBL] [Abstract][Full Text] [Related]
16. Effects of phospholipase D during cultured osteoblast mineralization and bone formation.
Abdallah D; Skafi N; Hamade E; Borel M; Reibel S; Vitale N; El Jamal A; Bougault C; Laroche N; Vico L; Badran B; Hussein N; Magne D; Buchet R; Brizuela L; Mebarek S
J Cell Biochem; 2019 Apr; 120(4):5923-5935. PubMed ID: 30320913
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells.
Lei C; Wang Y; Huang Y; Yu H; Huang Y; Wu L; Huang L
PLoS One; 2012; 7(12):e52310. PubMed ID: 23284982
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
[No Abstract] [Full Text] [Related]
19. Phospholipase D1 activation through Src and Ras is involved in basic fibroblast growth factor-induced neurite outgrowth of H19-7 cells.
Oh DY; Park SY; Cho JH; Lee KS; Min do S; Han JS
J Cell Biochem; 2007 May; 101(1):221-34. PubMed ID: 17146759
[TBL] [Abstract][Full Text] [Related]
20. PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer.
Nagumo Y; Kandori S; Tanuma K; Nitta S; Chihara I; Shiga M; Hoshi A; Negoro H; Kojima T; Mathis BJ; Funakoshi Y; Nishiyama H
Cancer Lett; 2021 Jul; 511():15-25. PubMed ID: 33945837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
